Commentary · 14 Mar 2025
Research articlePublished 28 Jun 2024
The Effects of Shilajit on Serum Levels of Cytokines and Adipokines in Rats with the Non-Alcoholic Fatty Liver Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background/Objectives: The non-alcoholic fatty liver disease is a common cause of chronic liver disease which associated with obesity and diabetes and has a worldwide outbreak. The aim of this study cytokines and adipokines caused by NAFLD. Methods: Thirty-five Wistar male rats after establish fatty liver models by feeding a high fat diet (HFD, 12 weeks) were randomly divided into five groups (n=7 rats/each group); control (standard diet), VEH (HFD+VEH), high dose Shilajit (HFD+250 mg/kg/day Shilajit by gavage for 2 weeks), low dose Shilajit (HFD+150 mg/kg/day Shilajit by gavage for 2 weeks), pioglitazone (HFD+10 mg/kg/day pioglitazone by gavage for 2 weeks). The serum levels of glucose, insulin, IL-1β, IL-6, TNF- α, IL-10, adiponectin and resistin were measured after the two-weeks of intervention. Results: The results showed that in VEH group the serum levels of glucose (p<0.001), insulin (p<0.001), IL-1β (p<0.05), IL-6 (p<0.05), TNF-α (p<0.05) and resistin (p<0.01) significantly increased, while IL-10 (p<0.001) and adiponectin (p<0.01) levels decreased in comparison to the control group. However, treatments with high and low doses of Shilajit as well as pioglitazone significantly decreased insulin resistance (p<0.001), serum levels of glucose (p<0.001), IL-1β (p<0.01), TNF-α (p<0.01) and resistin (p<0.01) while increased IL-10 (p<0.001) and adiponectin (p<0.01) in comparison to VEH group. Conclusion: The study showed that Shilajit by modulating the serum levels of cytokines, adipokines and reducing of Insulin resistance index can improve NAFLD.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacological Reports.
Opinion · 3 Mar 2025
COVID-19 Vaccinations Monitored for Safety and Effectiveness
Perspective · 3 Mar 2025
The Significance of Anticoagulant Main Categories
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacological Reports
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Baran Ghezelbash”
- BylineArticles whose byline prints “Nader Shahrokhi”
- BylineArticles whose byline prints “Mohammad Khaksari”
- BylineArticles whose byline prints “Gholamreza Asadikaram”
- BylineArticles whose byline prints “Sara Shirazpour”
